38
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Nitric oxide and downstream second messenger cGMP and cAMP enhance adipogenesis in primary human preadipocytes

, , , , , & show all
Pages 547-553 | Published online: 06 Apr 2010

References

  • Rossatti B. Revascularisation and phagocytosis in free fat autografts: an experimental study. Br J Plast Surg. 1960; 13:35–41.
  • Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest. 2005;115:1111–9.
  • Hemmrich K, Thomas GP, Abberton KM, Thompson EW, Rophael JA, Penington AJ, . Monocyte chemoattractant protein-1 and nitric oxide promote adipogenesis in a model that mimics obesity. Obesity (Silver Spring). 2007;15:2951–7.
  • Thomas GP, Hemmrich K, Abberton KM, McCombe D, Penington AJ, Thompson EW, . Zymosan-induced inflammation stimulates neo-adipogenesis. Int J Obes (Lond). 2008;32:239–48.
  • Christopherson KS, Bredt DS. Nitric oxide in excitable tissues: physiological roles and disease. J Clin Invest. 1997;100: 2424–9.
  • Schindler H, Bogdan C. NO as a signaling molecule: effects on kinases. Int Immunopharmacol. 2001;1:1443–55.
  • Elizalde M, Ryden M, van Harmelen V, Eneroth P, Gyllenhammar H, Holm C, . Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans. J Lipid Res. 2000;41:1244–51.
  • Engeli S, Janke J, Gorzelniak K, Bohnke J, Ghose N, Lindschau C, . Regulation of the nitric oxide system in human adipose tissue. J Lipid Res. 2004;45:1640–8.
  • Choi JW, Pai SH, Kim SK, Ito M, Park CS, Cha YN. Increases in nitric oxide concentrations correlate strongly with body fat in obese humans. Clin Chem. 2001;47:1106–9.
  • Andersson K, Gaudiot N, Ribiere C, Elizalde M, Giudicelli Y, Arner P. A nitric oxide-mediated mechanism regulates lipolysis in human adipose tissue in vivo. Br J Pharmacol. 1999;126: 1639–45.
  • Hrabie JA, Arnold EV, Citro ML, George C, Keefer LK. Reaction of nitric oxide at the beta-carbon of enamines. A new method of preparing compounds containing the diazeniumdiolate functional group. J Org Chem. 2000;65:5745–51.
  • Pairault J, Green H. A study of the adipose conversion of suspended 3T3 cells by using glycerophosphate dehydrogenase as differentiation marker. Proc Natl Acad Sci USA. 1979;76:5138–42.
  • Spiegelman BM, Ginty CA. Fibronectin modulation of cell shape and lipogenic gene expression in 3T3-adipocytes. Cell. 1983;35:657–66.
  • Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.
  • Patrick CW Jr, Zheng B, Johnston C, Reece GP. Long-term implantation of preadipocyte-seeded PLGA scaffolds. Tissue Eng. 2002;8:283–93.
  • Hemmrich K, von Heimburg D, Rendchen R, Di Bartolo C, Milella E, Pallua N. Implantation of preadipocyte-loaded hyaluronic acid-based scaffolds into nude mice to evaluate potential for soft tissue engineering. Biomaterials. 2005;26: 7025–37.
  • Stillaert FB, Di Bartolo C, Hunt JA, Rhodes NP, Tognana E, Monstrey S, . Human clinical experience with adipose precursor cells seeded on hyaluronic acid-based spongy scaffolds. Biomaterials. 2008;29:3953–9.
  • Nisoli E, Clementi E, Tonello C, Sciorati C, Briscini L, Carruba MO. Effects of nitric oxide on proliferation and differentiation of rat brown adipocytes in primary cultures. Br J Pharmacol. 1998;125:888–94.
  • Yan H, Aziz E, Shillabeer G, Wong A, Shanghavi D, Kermouni A, . Nitric oxide promotes differentiation of rat white preadipocytes in culture. J Lipid Res. 2002;43:2123–9.
  • Sciorati C, Nistico G, Meldolesi J, Clementi E. Nitric oxide effects on cell growth: GMP-dependent stimulation of the AP-1 transcription complex and cyclic GMP-independent slowing of cell cycling. Br J Pharmacol. 1997;122:687–97.
  • Klein C. Nitric oxide and the other cyclic nucleotide. Cell Signal. 2002;14:493–8.
  • Vila-Petroff MG, Younes A, Egan J, Lakatta EG, Sollott SJ. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res. 1999; 84:1020–31.
  • Uchida Y, Tsukahara F, Ohba K, Ogawa A, Irie K, Fujii E, . Nitric oxide mediates down regulation of lipoprotein lipase activity induced by tumor necrosis factor-alpha in brown adipocytes. Eur J Pharmacol. 1997;335:235–43.
  • Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991; 43:109–42.
  • Ibrahimi A, Abumrad N, Maghareie H, Golia M, Shoshani I, Desaubry L, . Adenylyl cyclase P-site ligands accelerate differentiation in Ob1771 preadipocytes. Am J Physiol. 1999; 276:C487–96.
  • Nishikimi T, Iemura-Inaba C, Akimoto K, Ishikawa K, Koshikawa S, Matsuoka H. Stimulatory and inhibitory regulation of lipolysis by the NPR-A/cGMP/PKG and NPR-C/G(i) pathways in rat cultured adipocytes. Regul Pept. 2008.
  • Fox KE, Fankell DM, Erickson PF, Majka SM, Crossno JT Jr, Klemm DJ. Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT/enhancer-binding protein (C/EBP) alpha, C/EBP beta, or PPAR gamma 2. J Biol Chem. 2006;281:40341–53.
  • Yang DC, Tsay HJ, Lin SY, Chiou SH, Li MJ, Chang TJ, . cAMP/PKA regulates osteogenesis, adipogenesis and ratio of RANKL/OPG mRNA expression in mesenchymal stem cells by suppressing leptin. PLoS ONE. 2008;3: e1540.
  • Galea E, Feinstein DL. Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP. FASEB J. 1999;13:2125–37.
  • Collins S, Daniel KW, Petro AE, Surwit RS. Strain-specific response to beta 3-adrenergic receptor agonist treatment of diet-induced obesity in mice. Endocrinology. 1997;138: 405–13.
  • Danforth E Jr, Himms-Hagen JH. Obesity and diabetes and the beta-3 adrenergic receptor. Eur J Endocrinol. 1997;136: 362–5.
  • Jobgen WS, Fried SK, Fu WJ, Meininger CJ, Wu G. Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. J Nutr Biochem. 2006;17:571–88.
  • Cummings DE, Brandon EP, Planas JV, Motamed K, Idzerda RL, McKnight GS. Genetically lean mice result from targeted disruption of the RII beta subunit of protein kinase A. Nature. 1996;382:622–6.
  • Petersen RK, Madsen L, Pedersen LM, Hallenborg P, Hagland H, Viste K, . Cyclic AMP (cAMP)-mediated stimulation of adipocyte differentiation requires the synergistic action of Epac- and cAMP-dependent protein kinase-dependent processes. Mol Cell Biol. 2008;28:3804–16.
  • Casimir DA, Ntambi JM. cAMP activates the expression of stearoyl-CoA desaturase gene 1 during early preadipocyte differentiation. J Biol Chem. 1996;271:29847–53.
  • Montolio M, Biarnes M, Tellez N, Escoriza J, Soler J, Montanya E. Interleukin-1beta and inducible form of nitric oxide synthase expression in early syngeneic islet transplantation. J Endocrinol. 2007;192:169–77.
  • Szabolcs MJ, Ravalli S, Minanov O, Sciacca RR, Michler RE, Cannon PJ. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation. 1998;65:804–12.
  • Cooke JP. NO and angiogenesis. Atheroscler Suppl. 2003;4: 53–60.
  • Jun HW, Taite LJ, West JL. Nitric oxide-producing polyurethanes. Biomacromolecules. 2005;6:838–44.
  • Pyriochou A, Beis D, Koika V, Potytarchou C, Papadimitriou E, Zhou Z, . Soluble guanylyl cyclase activation promotes angiogenesis. J Pharmacol Exp Ther. 2006;319:663–71.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.